About NeoMed

NeoMed Management is an international investment firm, exclusively focussing on the healthcare and life science industry. Founded in 1996, NeoMed has established four funds, with total committed capital exceeding $200 million.

NeoMed invests in young companies with outstanding growth prospects. Portfolio companies typically develop innovative products addressing inadequately served medical needs in the following industry sectors: pharmaceuticals, biotechnology drugs, diagnostics, medical devices and instruments.

NeoMed has a multi-stage investment approach and invests at all stages of development from start-up to later stage growth financings. Since inception, NeoMed has backed more than 30 companies in the USA and Europe, including Scandinavia, Switzerland, Germany and the UK.

From offices in Norway, Switzerland and the US East Coast, NeoMed’s investment team offers a broad network and experience in supporting the growth of its portfolio companies.

NeoMed is currently investing from its latest fund, NeoMed Innovation IV with about $125 m in total committed capital, and looks for initial investments in the range of $2.5 to $5 million.